Copertina

Emerging Molecular Targets in Neurodegenerative Disorders: New Avenues for Therapeutic Intervention

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Ezgi Eroglu, Nusin Harmanci
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Basic & Clinical Pharmacology & Toxicology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Neurodegenerative disorders: Advances in neurobiology and new treatment perspectives
di: Sâmia Joca
Pubblicazione: (2024)

Neuroprotective Effects of Esketamine in Central Nervous System Disorders: Mechanisms and Cellular Targets
di: Chendi Zhao, et al.
Pubblicazione: (2026)

Therapeutic Targeting of the α7 Nicotinic Receptor: Challenges and Prospects for Cognitive Improvement in Alzheimer's and Schizophrenia
di: Janus H. Magnussen
Pubblicazione: (2025)

Quality Assessment of Therapeutic Drug Monitoring Assays of Therapeutic Antibodies Across Europe: An Update
di: James Bluett, et al.
Pubblicazione: (2025)

Billing Deprescribing Interventions: Portrait of an Initiative in Québec, Canada
di: Alexandre Campeau Calfat, et al.
Pubblicazione: (2025)

Multidimensional Evaluation of Lisdexamfetamine: Pharmacology, Therapeutic Use, Toxicity and Forensic Implications
di: Mariana Silva‐Carvalho, et al.
Pubblicazione: (2025)

Therapeutic benefit of melatonin in 5‐fluorouracil‐induced renal and hepatic injury
di: Razieh Mansoori, et al.
Pubblicazione: (2024)

Disease of Conceit: Acetaminophen in Pregnancy and Neurodevelopmental Disorders
di: Per Damkier
Pubblicazione: (2025)

Pharmacokinetics of Perampanel in Danish Paediatric Patients With Epilepsy Based on Therapeutic Drug Monitoring
di: Sara Angelucci, et al.
Pubblicazione: (2026)

The Role of Hydroxychloroquine in the Management of Rheumatic Disorders: A Comprehensive Review
di: Ilker Ates, et al.
Pubblicazione: (2025)

Effects of GLP‐1 Receptor Agonists in Alcohol Use Disorder
di: Mette Kruse Klausen, et al.
Pubblicazione: (2025)

Drugs targeting APOE4 that regulate beta‐amyloid aggregation in the brain: Therapeutic potential for Alzheimer's disease
di: Joan Poblano, et al.
Pubblicazione: (2024)

Therapeutic applicability of cannabidiol and other phytocannabinoids in epilepsy, multiple sclerosis and Parkinson's disease and in comorbidity with psychiatric disorders
di: Maria de Fátima dos Santos Sampaio, et al.
Pubblicazione: (2024)

Ehrlich ascites carcinoma provokes renal toxicity and DNA injury in mice: Therapeutic impact of chitosan and maitake nanoparticles
di: Hamed A. Abosharaf, et al.
Pubblicazione: (2024)

Natural Compounds From Traditional Chinese Medicine Against Doxorubicin‐Induced Cardiotoxicity: Biological Mechanisms and Therapeutic Potential
di: Min Li, et al.
Pubblicazione: (2026)

Repurposing Hetrombopag for Multiple Myeloma by Targeting PNPO: A Celastrol‐Inspired Approach
di: Tianyi Yu, et al.
Pubblicazione: (2026)

Correction to ‘Effect of Bariatric Surgery on the Pharmacokinetics of Drugs Used for Attention‐Deficit Hyperactivity Disorder—A Case Series’
Pubblicazione: (2025)

Development of a Deprescribing Intervention for Proton Pump Inhibitors in Primary Care: A Co‐Design Approach With General Practitioners and Patients
di: Kristie Rebecca Weir, et al.
Pubblicazione: (2025)

Evaluation of a Pharmacist‐Led Intervention Focused on the Deprescribing of Cardiovascular and Antidiabetic Medication in Older Patients With Polypharmacy: Patients' and Pharmacists' Experiences
di: Jamila Abou, et al.
Pubblicazione: (2026)

Facilitating the Implementation of Physician‐Led Medication Reviews for Patients With Severe Mental Disorder and Diabetes: A Cost‐Minimization Analysis
di: Johan Frederik Mebus Meyer Christensen, et al.
Pubblicazione: (2025)

Assessing the Carcinogenic Potential of PFOA: A Molecular Network Approach to Liver Toxicity
di: Libi Tan, et al.
Pubblicazione: (2025)

The Molecular and Clinical Impact of Atorvastatin Exposure on Paclitaxel Neurotoxicity in Sensory Neurons and Cancer Patients
di: Emma Simonsen, et al.
Pubblicazione: (2025)

Association Between Levels of the Acute Phase Proteins Alpha‐1‐Acid Glycoprotein and C‐Reactive Protein and Serum Concentrations of Clozapine: A Study of 1106 Therapeutic Drug Monitoring Samples
di: Ketil Arne Espnes, et al.
Pubblicazione: (2026)

Bruceine A Inhibits Cell Proliferation by Targeting the USP13/PARP1 Signalling Pathway in Multiple Myeloma
di: Mengjie Guo, et al.
Pubblicazione: (2025)

Computer‐Assisted Screening of Active Compounds in Traditional Chinese Medicine Targeting SNX10 as a Promising Treatment for Inflammatory Bowel Diseases
di: Yongpan An, et al.
Pubblicazione: (2025)

Multi‐Target Renal Protection of Wine‐Processed Polygonatum sibiricum Against Cisplatin‐Induced Nephrotoxicity: Integrated Phytochemistry, Network Pharmacology and Experimental Validation
di: Yu Jiang, et al.
Pubblicazione: (2025)

Epidemiology of New Psychoactive Substances in Relation to Traditional Drugs of Abuse in Clinical Oral Fluid Samples
di: Magnus A. B. Axelsson, et al.
Pubblicazione: (2025)

New Monitoring Recommendations for Digoxin During the Last Decade Are Associated With Decreased Serum Digoxin Concentrations in Patient Samples
di: Anders Larsson, et al.
Pubblicazione: (2025)

Electrochemical Point‐of‐Care Test for Assessing Serum Paracetamol Concentration: Comparison With Traditional Methods and Detection of Concomitant Drugs
di: Johanna K. Kujala, et al.
Pubblicazione: (2025)

Eugenol Alleviates Cerebral Ischemia–Reperfusion Injury in Mice by Promoting the Phagocytosis of Microglia via Up‐Regulating Tripartite Motif Protein 59
di: Mengtian Pan, et al.
Pubblicazione: (2025)

The Effects of Drugs on CYP3A Enzyme Activity and Protein Expression Through Ubiquitination Modification Regulation
di: Fang Wang, et al.
Pubblicazione: (2025)

Correction to ‘β‐LAPachone Ameliorates Doxorubicin‐Induced Cardiotoxicity via Regulating Autophagy and Nrf2 Signalling Pathways in Mice’
Pubblicazione: (2025)

The Pathobiology of Cerebrovascular Lesions in CADASIL Small Vessel Disease
di: Anne Joutel
Pubblicazione: (2025)

Foetal Exposure to Phthalates and Endocrine Effects on the Leydig Cell
di: Sarah Philbert Nielsen, et al.
Pubblicazione: (2025)

Healthcare Providers' Perspectives on Antidepressant Discontinuation: A Focus Group Study
di: S. Bouarfa, et al.
Pubblicazione: (2025)

Plasma NGAL, suPAR, KIM‐1 and GDF‐15 for Improving Glomerular Filtration Rate Estimation in Older Hospitalized Patients
di: Morten Baltzer Houlind, et al.
Pubblicazione: (2025)

Traditional Chinese Medicine for Inhibiting Ferroptosis in Ischemic‐Related Diseases
di: Yukun Zhang, et al.
Pubblicazione: (2025)

Application of Artificial Intelligence in the Development of Traditional Chinese Medicine
di: Xuebing He, et al.
Pubblicazione: (2025)

LW‐AFC Protects Against Neurological and Neuropsychiatric Effects of SARS‐CoV‐2 Spike Protein in Mice
di: Wenyi Xiao, et al.
Pubblicazione: (2025)

Emergency Department Visits due to Medication Overdose in a Finnish University Hospital
di: Sami Mustajoki, et al.
Pubblicazione: (2025)